Isoprenyl-transferase-inhibitorer

Det beskrives peptidomimetiske forbindelser som er anvendelige ved behandling av Ras-assosierte kreftformer og andre tilstander mediert av farnesylerte eller geranyl-geranylerte proteiner, samt syntetiske mellomprodukter derav. PCT No. PCT/US95/03387 Sec. 371 Date Mar. 19, 1997 Sec. 102(e) Date Mar....

Full description

Saved in:
Bibliographic Details
Main Authors LEWIS, MICHAEL D, YOSHIMATSU, KENTARO, CHRISTUK, AMY E, YANG, HU, KOWALCZYK, JAMES J, GARCIA, ANA MARIA, FAN, RULIN, HARRINGTON, EDMUND M, SHENG, XIAONING C, HISHINUMA, IEHARU, NAGASU, TAKESHI
Format Patent
LanguageNorwegian
Published 13.11.1996
Edition6
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Det beskrives peptidomimetiske forbindelser som er anvendelige ved behandling av Ras-assosierte kreftformer og andre tilstander mediert av farnesylerte eller geranyl-geranylerte proteiner, samt syntetiske mellomprodukter derav. PCT No. PCT/US95/03387 Sec. 371 Date Mar. 19, 1997 Sec. 102(e) Date Mar. 19, 1997 PCT Filed Mar. 15, 1995 PCT Pub. No. WO95/25086 PCT Pub. Date Sep. 21, 1995Peptidomimetic compounds useful in the treatment of Ras-associated human cancers, and other conditions mediated by farnesylated or geranylgeranylated proteins; and synthetic intermediates thereof.
Bibliography:Application Number: NO19960003860